Ligand validation:5VLX

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5VLX_GOL_B_204	53%	69%	0.15	0.91	0.53	0.66	-	-	0	0	100%	0.98
5VLX_GOL_A_205	24%	65%	0.217	0.849	0.74	0.6	-	-	2	0	100%	0.9
5VLX_GOL_B_205	22%	85%	0.152	0.765	0.51	0.24	-	-	0	0	100%	1
5VLX_GOL_A_204	19%	56%	0.244	0.84	0.64	1.06	-	-	0	0	100%	0.86
5VTT_GOL_B_205	55%	69%	0.163	0.931	0.55	0.66	-	-	0	0	100%	1
5VTS_GOL_B_205	54%	92%	0.14	0.904	0.39	0.13	-	-	1	0	100%	0.9
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.